Absence of PSA Flare With Apalutamide Administered 1 Hour in Advance With GnRH Agonists: Case Report

Absence of PSA Flare With Apalutamide Administered 1 Hour in Advance With GnRH Agonists: Case Report

ObjectiveTo examine the effects of apalutamide on endocrine function and flare prevention in metastatic hormone-sensitive prostate cancer (mHSPC) patients administered GnRH agonists.MethodsThe first newly diagnosed mHSPC patient took apalutamide for 2 weeks followed by combination with GnRH agonist,...

Full description

Bibliographic Details
Main Authors: Zhiquan Hu, Zhenghao Liu, Zhiyuan Chen, Xing Zeng, Zhihua Wang, Chunguang Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
hormone-sensitive prostate cancer
ADT
GnRH agonist
flare
apalutamide
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.878264/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.878264/full

Similar Items